Status:
UNKNOWN
Light Needle for Opioid Use Disorder
Lead Sponsor:
Chang Gung Memorial Hospital
Collaborating Sponsors:
Kaohsiung Medical University
Conditions:
Opioid Use Disorder
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
This randomized-controlled study investigates the effect of adjuvant light needle in the treatment of heroin addicts. One hundred heroin addicts older than 20 years old enrolled from the Addiction Tre...
Detailed Description
Background: Heroin addiction remains a significant public health problem worldwide, and relapse to heroin use following cessation of agonist maintenance treatment is common. The problems associated wi...
Eligibility Criteria
Inclusion
- A diagnosis of OUD is confirmed using the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Subjects aged 20-70 years with OUD who have received methadone maintenance treatment for at least 1 month and provided informed consent are being recruited. Psychiatrists assess each prospective participant's eligibility to be enrolled in the study.
Exclusion
- Subjects with a critical illness
- those who have taken Chinese herbs or received acupuncture treatment during the previous 30 days
- those who are unsuitable for recruitment in the opinion of the attending physician
- those who are unwilling to provide informed consent are excluded.
Key Trial Info
Start Date :
March 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 14 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05341219
Start Date
March 18 2022
End Date
February 14 2024
Last Update
May 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan, 833